Immune Pharmaceuticals News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

19.02.19	Immune Pharma Files For Chapter 11 Bankruptcy (RTTNews)
27.09.17	Immune Pharma: Bertilimumab Trial In Bullous Pemphigoid Shows Positive Results (RTTNews)
05.09.17	Recent Developments in the Pharmaceutical Industry (PR Newswire)
30.08.17	APRI Makes 2nd Try, PRQR To Reveal Data On Sep.25, PFE Awaits FDA Decision (RTTNews)
01.08.17	Today's Research Report Coverage on Healthcare Stocks -- Perrigo, Immune Pharma, Tonix Pharma, and United Therapeutics (PR Newswire)
20.07.17	SRPT Soars On Q2 Results & Outlook, AERI's Mercury-1 Does An Encore, ALIM Abuzz (RTTNews)
05.07.17	IMMUNE Pharmaceuticals' Oncology Subsidiary, CYTOVIA, Announces Additional Clinical Trial Results on the Efficacy of Ceplene® in Combination with Low-Dose IL-2 in Patients With Acute Myeloid... (PR Newswire)
29.06.17	Immune Pharmaceuticals' Oncology Subsidiary, Cytovia Inc. Provides Update to Proposed Pint Pharma Transaction: Substantial Agreement Reached on Material Terms of the Licensing and Commercialization... (PR Newswire)
20.06.17	Immune Pharmaceuticals announces initiation of enrollment in clinical trial with Ceplene®/ low-dose IL-2 in Chronic Myelomonocytic Leukemia (CMML) (PR Newswire)
19.06.17	Immune Receives NASDAQ Compliance Letter (PR Newswire)
15.06.17	Immune Pharmaceuticals Signs Agreement to Regain Worldwide Rights for Ceplene (PR Newswire)
02.06.17	Research Reports Initiation on Drug Makers Stocks -- Immune Pharma, Impax Labs, Heron Therapeutics, and Alimera Sciences (PR Newswire)
26.05.17	Immune Receives Nasdaq Letters (PR Newswire)
04.05.17	Immune Pharmaceuticals Announces Private Placement of up to $3.4 Million (PR Newswire)
24.04.17	Immune Pharmaceuticals Announces Corporate Restructuring (PR Newswire)
24.04.17	Immune Receives Nasdaq Letter (PR Newswire)
24.04.17	Drug Makers Stocks Under Scanner -- Bristol-Myers, AstraZeneca, Eli Lilly, and Immune Pharma (PR Newswire)
20.04.17	Immune Pharmaceuticals Signs Letter of Intent with Pint Pharma Regarding License and Commercializion of Ceplene® in Latin America (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V